A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

HIV and Aids campaigns are often targeted at the youth. But new research has found high prevalence rates among older people.

A cross-sectional analysis shows that long-acting antiretroviral therapy sustains viral suppression regardless of initial ...

Patients attending Medway Maritime Hospital's A&E will now be routinely tested for HIV and hepatitis unless they opt out. The ...

People living with HIV are less likely to receive potentially lifesaving cancer treatment if they live in communities with ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

On April 22, the CDC allegedly informed Emory University in Atlanta that its large HIV self-testing program was being ...

HIV rates are rising among adults over 50 but prevention efforts still focus on youth Experts warn this oversight could derail global HIV targets and worsen outcomes ...

However, researchers at Scripps Research used computer modeling to show how certain antibodies target lipids to recognize the HIV virus, offering insights for better vaccine development for HIV an ...

While the Kyrgyz government fully covers HIV treatment, there’s a real risk that essential social and prevention services — post-release support, reintegration, temporary housing, documentation help, ...